Skip to main content

Dexcom ownership: holders and insider trading

  • DXCM · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$83.33+2.38%Close 13 Nov 2026 · Market value $30.72B

As filed, its directors and officers own 0.3% of the shares (proxy statement, 1 Apr 2026); 971 institutional managers reported holding 99.7% at 30 Jun 2026. Over the last twelve months, insiders sold $12.52M of shares on the open market, $12.52M of it under 10b5-1 plans set in advance, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
Vanguard subsidiaries or business divisionsHolder49.5M12.8%Proxy statement1 Apr 2026
VanguardInstitution48.9M13.11%*Form 13F30 Jun 2026
BlackRock, Inc.Holder38.2M10.25%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder28.8M7.49%Schedule 13G31 Mar 2026
Vanguard Portfolio ManagementHolder19.3M5.02%Schedule 13G31 Mar 2026
State StreetInstitution18.9M5%Schedule 13G30 Sep 2026
UBSInstitution17.3M4.65%*Form 13F30 Jun 2026
InvescoInstitution15.3M4.10%*Form 13F30 Jun 2026
Baillie Gifford & CoInstitution14.8M3.97%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution12.4M3.33%*Form 13F30 Jun 2026
Alliancebernstein L.p.Institution11.7M3.13%*Form 13F30 Jun 2026
Wellington ManagementInstitution8.5M2.29%*Form 13F30 Jun 2026
Arrowstreet Capital, Limited PartnershipInstitution6.9M1.84%*Form 13F30 Jun 2026
Norges BankInstitution6.9M1.84%*Form 13F30 Jun 2026
AmundiInstitution5.6M1.50%*Form 13F30 Jun 2026
Morgan StanleyInstitution5.2M1.38%*Form 13F30 Jun 2026
AmeripriseInstitution4.8M1.29%*Form 13F30 Jun 2026
Castle Hook Partners LPInstitution3.9M1.04%*Form 13F30 Jun 2026
Goldman SachsInstitution3.8M1.01%*Form 13F30 Jun 2026
Franklin TempletonInstitution3.6M0.96%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Brown Michael Jon · EVP Chief Legal Compliance Off8 Nov 2026Shares withheld for tax−1.5K$79.41$115.2K
Leach Jacob Steven · President, CEO, and Director · Director8 Nov 2026Shares withheld for tax−1.5K$79.41$115.2K
Stern Sadie · EVP Chief People & Culture Off8 Nov 2026Shares withheld for tax−1.5K$79.41$115.2K
Sylvain Jereme M · EVP, COO & CFO8 Nov 2026Shares withheld for tax−1.5K$79.41$115.2K
Stern Sadie · EVP Chief People & Culture Off27 Oct 2026Open-market sale (10b5-1 plan)−2.6K$78.62$201.7K
Brown Michael Jon · EVP Chief Legal Compliance Off15 Oct 2026Open-market sale (10b5-1 plan)−1.7K$85.48$145.3K
Stern Sadie · EVP Chief People & Culture Off28 Sep 2026Open-market sale (10b5-1 plan)−2.6K$86.15$221.0K
AUGUSTINOS NICHOLAS · Director15 Sep 2026Open-market sale (10b5-1 plan)−6.5K$84.04$549.5K
Brown Michael Jon · EVP Chief Legal Compliance Off15 Sep 2026Open-market sale (10b5-1 plan)−1.7K$84.04$142.9K
AUGUSTINOS NICHOLAS · Director14 Sep 2026Open-market sale (10b5-1 plan)−1.6K$84.02$130.2K
Sylvain Jereme M · EVP, Chief Financal Officer10 Sep 2026Open-market sale (10b5-1 plan)−3.6K$83.27$302.9K
Boehnlein Glenn S · Director10 Sep 2026Grant or award+5.8K——
Stern Sadie · EVP Chief People & Culture Off27 Aug 2026Open-market sale (10b5-1 plan)−2.6K$88.37$226.7K
Leach Jacob Steven · President, CEO, and Director · Director22 Aug 2026Shares withheld for tax−1.5K$92.34$134.0K
Sylvain Jereme M · EVP, Chief Financal Officer22 Aug 2026Shares withheld for tax−1.5K$92.34$134.0K
Brown Michael Jon · EVP Chief Legal Compliance Off22 Aug 2026Shares withheld for tax−1.5K$92.34$134.0K
Stern Sadie · EVP Chief People & Culture Off22 Aug 2026Shares withheld for tax−1.5K$92.34$134.0K
SAYER KEVIN R · Executive Chair · Director20 Aug 2026Open-market sale (10b5-1 plan)−19.3K$89.71$1.73M
SAYER KEVIN R · Executive Chair · Director20 Aug 2026Open-market sale (10b5-1 plan)−7.4K$90.78$667.3K
SAYER KEVIN R · Executive Chair · Director20 Aug 2026Open-market sale (10b5-1 plan)−97$91.41$8.87K
Brown Michael Jon · EVP Chief Legal Compliance Off14 Aug 2026Open-market sale (10b5-1 plan)−1.7K$91.93$156.3K
Heller Bridgette P · Director12 Aug 2026Open-market sale (10b5-1 plan)−1.0K$88.29$89.35K
FOLETTA MARK G · Director3 Aug 2026Open-market sale (10b5-1 plan)−2.0K$85.32$170.6K
FOLETTA MARK G · Director31 Jul 2026Open-market sale (10b5-1 plan)−2.0K$80.00$160.0K
SAYER KEVIN R · Executive Chair · Director20 Jul 2026Open-market sale (10b5-1 plan)−26.8K$76.32$2.04M

Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

DXCM in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.